Literature DB >> 19662685

Hepatic energy state is regulated by glucagon receptor signaling in mice.

Eric D Berglund1, Robert S Lee-Young, Daniel G Lustig, Sara E Lynes, E Patrick Donahue, Raul C Camacho, M Elizabeth Meredith, Mark A Magnuson, Maureen J Charron, David H Wasserman.   

Abstract

The hepatic energy state, defined by adenine nucleotide levels, couples metabolic pathways with energy requirements. This coupling is fundamental in the adaptive response to many conditions and is impaired in metabolic disease. We have found that the hepatic energy state is substantially reduced following exercise, fasting, and exposure to other metabolic stressors in C57BL/6 mice. Glucagon receptor signaling was hypothesized to mediate this reduction because increased plasma levels of glucagon are characteristic of metabolic stress and because this hormone stimulates energy consumption linked to increased gluconeogenic flux through cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C) and associated pathways. We developed what we believe to be a novel hyperglucagonemic-euglycemic clamp to isolate an increment in glucagon levels while maintaining fasting glucose and insulin. Metabolic stress and a physiological rise in glucagon lowered the hepatic energy state and amplified AMP-activated protein kinase signaling in control mice, but these changes were abolished in glucagon receptor- null mice and mice with liver-specific PEPCK-C deletion. 129X1/Sv mice, which do not mount a glucagon response to hypoglycemia, displayed an increased hepatic energy state compared with C57BL/6 mice in which glucagon was elevated. Taken together, these data demonstrate in vivo that the hepatic energy state is sensitive to glucagon receptor activation and requires PEPCK-C, thus providing new insights into liver metabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19662685      PMCID: PMC2719934          DOI: 10.1172/jci38650

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  76 in total

1.  Energy state of the liver during short-term and exhaustive exercise in C57BL/6J mice.

Authors:  Raul C Camacho; E Patrick Donahue; Freyja D James; Eric D Berglund; David H Wasserman
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-10-11       Impact factor: 4.310

Review 2.  AMP-activated protein kinase--development of the energy sensor concept.

Authors:  D Grahame Hardie; Simon A Hawley; John W Scott
Journal:  J Physiol       Date:  2006-04-27       Impact factor: 5.182

3.  Intense exercise induces the degradation of adenine nucleotide and purine nucleotide synthesis via de novo pathway in the rat liver.

Authors:  Toshio Mikami; Jun Kitagawa
Journal:  Eur J Appl Physiol       Date:  2005-12-21       Impact factor: 3.078

4.  5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.

Authors:  Raul C Camacho; D Brooks Lacy; Freyja D James; E Patrick Donahue; David H Wasserman
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-07-26       Impact factor: 4.310

5.  Mitochondrial dysfunction and type 2 diabetes.

Authors:  Bradford B Lowell; Gerald I Shulman
Journal:  Science       Date:  2005-01-21       Impact factor: 47.728

6.  Portal venous 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output.

Authors:  Raul C Camacho; R Richard Pencek; D Brooks Lacy; Freyja D James; E Patrick Donahue; David H Wasserman
Journal:  Diabetes       Date:  2005-02       Impact factor: 9.461

7.  5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside causes acute hepatic insulin resistance in vivo.

Authors:  R Richard Pencek; Jane Shearer; Raul C Camacho; Freyja D James; D Brooks Lacy; Patrick T Fueger; E Patrick Donahue; Wanda Snead; David H Wasserman
Journal:  Diabetes       Date:  2005-02       Impact factor: 9.461

8.  Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse.

Authors:  Julio E Ayala; Deanna P Bracy; Owen P McGuinness; David H Wasserman
Journal:  Diabetes       Date:  2006-02       Impact factor: 9.461

9.  Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase.

Authors:  Scot R Kimball; Brett A Siegfried; Leonard S Jefferson
Journal:  J Biol Chem       Date:  2004-10-19       Impact factor: 5.157

10.  Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase.

Authors:  Shawn C Burgess; Natasha Hausler; Matthew Merritt; F Mark H Jeffrey; Charles Storey; Angela Milde; Seena Koshy; Jill Lindner; Mark A Magnuson; Craig R Malloy; A Dean Sherry
Journal:  J Biol Chem       Date:  2004-09-03       Impact factor: 5.157

View more
  42 in total

1.  Augmenting energy expenditure by mitochondrial uncoupling: a role of AMP-activated protein kinase.

Authors:  Susanne Klaus; Susanne Keipert; Martin Rossmeisl; Jan Kopecky
Journal:  Genes Nutr       Date:  2011-12-04       Impact factor: 5.523

2.  Exercise: not just a medicine for muscle?

Authors:  John P Thyfault; R Scott Rector
Journal:  J Physiol       Date:  2010-08-01       Impact factor: 5.182

Review 3.  Exercise and the Regulation of Hepatic Metabolism.

Authors:  Elijah Trefts; Ashley S Williams; David H Wasserman
Journal:  Prog Mol Biol Transl Sci       Date:  2015-08-05       Impact factor: 3.622

4.  Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.

Authors:  Young Lee; Eric D Berglund; Xinxin Yu; May-Yun Wang; Matthew R Evans; Philipp E Scherer; William L Holland; Maureen J Charron; Michael G Roth; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

5.  Impaired glucose tolerance, glucagon, and insulin responses in mice lacking the loop diuretic-sensitive Nkcc2a transporter.

Authors:  Lisa Kelly; Mohammed M Almutairi; Shams Kursan; Romario Pacheco; Eduardo Dias-Junior; Hayo Castrop; Mauricio Di Fulvio
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-31       Impact factor: 4.249

6.  5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.

Authors:  Clinton M Hasenour; D Emerson Ridley; Curtis C Hughey; Freyja D James; E Patrick Donahue; Jane Shearer; Benoit Viollet; Marc Foretz; David H Wasserman
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

Review 7.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

8.  Pyruvate-Carboxylase-Mediated Anaplerosis Promotes Antioxidant Capacity by Sustaining TCA Cycle and Redox Metabolism in Liver.

Authors:  David A Cappel; Stanisław Deja; João A G Duarte; Blanka Kucejova; Melissa Iñigo; Justin A Fletcher; Xiaorong Fu; Eric D Berglund; Tiemin Liu; Joel K Elmquist; Suntrea Hammer; Prashant Mishra; Jeffrey D Browning; Shawn C Burgess
Journal:  Cell Metab       Date:  2019-04-18       Impact factor: 27.287

9.  Mass spectrometry-based microassay of (2)H and (13)C plasma glucose labeling to quantify liver metabolic fluxes in vivo.

Authors:  Clinton M Hasenour; Martha L Wall; D Emerson Ridley; Curtis C Hughey; Freyja D James; David H Wasserman; Jamey D Young
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-05-19       Impact factor: 4.310

10.  Effects of low and high doses of fenofibrate on protein, amino acid, and energy metabolism in rat.

Authors:  Milan Holeček; Melita Vodeničarovová
Journal:  Int J Exp Pathol       Date:  2020-09-01       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.